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Abstract 
 
  Wine is composed of a variety of tannins, of which a sub-class includes salidrosides, which are 
largely uninvestigated compounds.  The first syntheses of galloylated salidrosides are reported in 7 
steps from commercially available starting materials through a platform approach. The antimicrobial 
activity of the salidrosides against E. coli strains is described. 
 
Keywords 
  
Wine polyphenols, Tannins, Salidroside, Galloyl-substituted salidrosides, Antimicrobial activity 
 
1. Introduction 
 
 Wine has a complex and varied chemical composition from which numerous health benefits 
arise upon moderate consumption.  Advances in analytical instrumentation have revealed potent 
bioactive components that contribute to wine’s positive effects despite their presence in low levels.1  
Natural heterocycles in wine were featured in an extensive review by Wamhoff and Gribble2,3 which 
are associated with color, astringency, and oxidation rate during the aging process.3  Another class of 
biologically-active compounds in red wine includes polyphenols like resveratrol (Figure 1).  As a 
class, polyphenols broadly exhibit antimicrobial and antioxidant activity and prevent cardiovascular 
disorders; in vitro studies also support their inhibition of cancer cell growth.4-7  The polyphenols 
termed tannins become incorporated into wine when it is stored in tannin-rich oak barrels.8,9 As 
astringents, tannins not only enhance the perceived taste and smell of the wine, but they also decrease 
blood pressure and facilitate blood clotting.10  
 
 
 
 
Figure 1.  Structures of selected natural polyphenols found in wine – resveratrol (1), quercetin (2), 
catechin (3), and tyrosol (4)  
 
Hydrolyzable tannins include gallotannin and the emerging class of ellagitannin natural 
products, including penta-O-galloyl-D-glucopyranoside (5) and tellimagrandin I (6), respectively, 
which are based on their defining core structures (Figure 2). While ellagitannins are characterized by 
galloyl groups connected by oxidation to become hexahydroxydiphenoyl units, gallotannins generally 
have galloyl moieties in free rotation.  The structures of over a thousand naturally-occurring 
ellagitannins have been elucidated; their challenging molecular architecture and biological activity 
have made them popular synthetic targets for organic chemists.11-14  
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Figure 2.  Representative gallotannin, ellagitannin, and salidroside structures. 
  
Salidrosides contain a p-hydroxyphenethyl alcohol unit connected through an ether linkage at 
C-1” to form a tyrosol glycoside.  In China, naturally-occurring salidrosides have been commonly 
added to wines to produce “health wines” which are claimed to promote immunity and additionally 
have anti-fatigue and antioxidant properties.15-17  The simplest salidroside (7), the most well-studied 
example, could potentially treat neurodegenerative diseases since it ameliorates cell apoptosis 
triggered by oxidative stress.18,19   
While the scientific literature has detailed studies to of the biological activity of salidroside (7), 
the structure-activity relationship of more substituted analogues have remained largely uninvestigated 
mainly due to the inadequate availability of comprehensive libraries.  Based on the structural trend 
observed with other tannins, we predicted that galloyllated salidrosides would influence the resulting 
biological activity.  We created a platform approach to access galloyl-substituted salidroside members, 
for which syntheses have never been reported.  We envisioned that providing unique polyphenol 
compounds would allow researchers to systematically and more thoroughly analyze the structure-
activity relationship. 
The more complex salidroside derivatives we targeted contain galloyl units attached to the 
glucose moiety, which include 2”,3”,4”,6”-tetra-O-galloyl salidroside (8) and the 6”-O-galloyl 
salidroside (9) which were isolated from the bark of Quercus stenophylla Makino20,21 (Figure 3).  
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Figure 3. Galloyl-substituted salidrosides from Quercus stenophylla Makino. 
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2. Results and Discussion 
  
We first began by synthesizing salidroside (7) to obtain a synthetic sample to use as a 
comparison for the biological activity analyses.  We designed a synthetic strategy to take advantage of 
the common intermediate 2-(4-benzyloxyphenyl)ethyl β-D-glucopyranoside (11) which could readily 
be manipulated to generate diverse analogues.  Our synthesis towards intermediate 11 commenced by 
coupling 2-(4-benzyloxyphenyl)ethanol22 and commercially available 2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl bromide 10 mediated by Ag2CO3.  The resultant crude mixture was directly 
deacetylated using sodium methoxide to generate 11.  Hydrogenation with palladium on carbon 
generated salidroside 7 in 83% yield, where all characterization data matched those previously 
reported in the literature (Scheme 1).23   
After achieving salidroside (7) as a benchmark for comparison, the synthesis of 8 began by 
treating 11 with 3,4,5-tribenzyloxybenzoyl chloride, which in turn was prepared in three steps from 
methyl gallate.24  Tribenzylgalloyl groups were installed in the presence of DMAP, generating 
salidroside 12 in 79% yield, which was followed by global deprotection to furnish 8 in 72% yield.   
Finally, the synthesis of 9 required selective esterification of 11.  We initially attempted to 
facilitate the controlled addition of the tribenzyloxybenzoyl group to 11 with Me2SnCl2 and DIPEA; 
however, the reaction conditions were not selective and only provided complex mixtures.  To improve 
the selective esterification on the C-6” position, we modified the conditions previously used to obtain 
12 and reduced the equivalents of DMAP relative to the 3,4,5-tribenzyloxybenzoyl chloride to provide 
13 in 24% yield after a period of 72 hours.  Salidroside 9 was achieved in 80% yield after 
hydrogenation. 
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Scheme 1. Reaction conditions: (a) 2-(4-Benzyloxyphenyl)ethanol, Ag2CO3, CH2Cl2, rt, 24 h; (b) 
MeONa/MeOH, rt, 16 h, 55% over two steps; (c) H2, Pd/C, THF, 40 oC, 24 h, 83%; (d) 3,4,5-
Tribenzyloxybenzoyl chloride, DMAP, MeCN, rt, 24 h, 79%; (e) 3,4,5-Tribenzyloxybenzoyl chloride, 
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DMAP, pyridine, rt, 72 h, 24%; (f) H2, Pd/C, THF, 40 oC, 24 h, 72%; (g) H2, Pd/C, THF, 40 oC, 24 h, 
80%.   
 Once the salidroside analogues were prepared, they were ready for biological testing.  The 
antimicrobial activity of salidrosides 7, 8, and 9 was tested using a disc diffusion assay as described by 
us previously25 using wild-type Escherichia coli K-12 (strain MG1655). Tests were repeated three 
times to check for reproducibility. The diameter measurements of the zones of inhibition for E. coli 
MG1655 were as follows:  salidroside 7: 0 mm; salidroside 8: 18 mm; salidroside 9: 22 mm. The 
antibiotic ampicillin (100 µg/ml) gave a zone of inhibition of 35 mm while the DMSO solvent control 
gave 0 mm.    
 
3. Conclusion 
 
In summary, wine is comprised of a complex portfolio of compounds that include polyphenols.  
Among the polyphenols, the class of tannins has emerged as an attractive research topic to discover 
potential benefits to human health.  Specifically, the biological activity of salidrosides has remained 
uninvestigated. We report the first synthesis of galloyl-substituted salidrosides in 7 steps from 
commercially available starting materials.  The synthetic strategy utilizes a platform intermediate from 
which additional diversity can be generated.  Galloylated salidrosides 8 and 9 revealed that they 
exhibit effective antimicrobial activity which could be applied toward the synthesis of additional 
analogues to investigate the structure-activity relationship. 
   
 
4. Experimental Section 
 
4.1. General Methods 
All starting materials were purchased from Sigma-Aldrich; solvents were purchased from Fisher 
Scientific and used without further purification.  Palladium, 5% on activated carbon was purchased 
from Strem Chemicals (product number: 46-1747).  All reactions were carried out in flame-dried 
glassware under argon with dry solvents under anhydrous conditions unless otherwise specified.  All 
yields refer to chromatographically isolated products. Reactions were monitored by thin-layer 
chromatography (TLC) and carried out on 0.20 mm silica gel plates using UV light as a visualizing 
agent and either potassium permanganate or 5% sulfuric acid in methanol with heat as developing 
agents.  Silica gel 60A, particle size 0.032 – 0.063 mm, was used for flash column chromatography.  
1H and 13C NMR spectra were acquired on a Varian MR-400 or Bruker Avance III 600 MHz 
spectrometer. 1H and 13C chemical shifts (δ) are given in ppm relative to the residual protonated 
solvent peak (CDCl3: δH = 7.26 ppm, δC = 77.0 ppm; CD3OD: δH = 3.31 ppm, δC = 49.0 ppm; 
(CD3)2SO: δH = 2.50 ppm, δC = 39.52 ppm; (CD3)2CO: δH = 2.05 ppm, δC = 29.84 ppm) as an 
internal reference. High-resolution mass spectra (HRMS) were recorded on an Agilent 6540 QTOF 
(quadrupole time of flight) mass spectrometer using ESI (electrospray ionization). 
 
4.2.  2-(4-benzyloxyphenyl)ethyl β-D-glucopyranoside (11) 
 
Over the course of the reaction, the flask was protected from light. To a solution of 2-(4-
benzyloxyphenyl)ethanol (1.37 g, 6.0 mmol) in dichloromethane (7.5 mL) was added molecular sieves 
(4Å, ~1.0 g) and Ag2CO3 (1.38 g, 5.0 mmol).  The resulting mixture was stirred for 15 minutes at 
room temperature, then the solution of 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide (2.06 g, 5.0 
mmol) in dichloromethane (7.5 mL) was added dropwise over 5 min.  The resulting mixture was 
stirred at room temperature for 24 h then filtered through a pad of Celite. The filtrate was then washed 
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with aqueous NaHCO3 (20 mL) and brine (20 mL), dried over sodium sulfate, and concentrated in 
vacuo.  The crude product was subjected to the next reaction without purification.  The crude solid was 
dissolved in methanol (25 mL) after which NaOMe (0.40 g, 7.5 mmol) was added.  The resulting 
mixture was stirred for 16 h at room temperature. Concentrated HCl was added dropwise to adjust the 
pH to 6-7 after which the neutralized mixture was then concentrated in vacuo. The crude product was 
purified by flash column chromatography (silica gel, MeOH:CH2Cl2 1% to 10%) to give 11 (1.11 g, 
55%) as a white solid; m.p. 88-89 oC; Rf (10% MeOH/CH2Cl2) 0.16; dH (400 MHz CD3OD) 7.42 
(2H, d, J 6.9 Hz), 7.36 (2H, t, J 7.3 Hz), 7.29 (1H, t, J 7.2 Hz), 7.17 (2H, d, J 8.5 Hz), 6.90 (2H, d, J 
8.6 Hz), 5.05 (2H, s), 4.29 (1H, d, J 7.8 Hz), 4.05 (1H, dt, J 9.5, 7.4 Hz), 3.89 – 3.83 (1H, m), 3.75 – 
3.69 (1H, m), 3.66 (1H, dd, J 11.9, 5.3 Hz), 3.37 – 3.33 (1H, m), 3.28 – 3.24 (2H, m), 3.18 (1H, t, J 7.6 
Hz), 2.87 (2H, t, J 7.8 Hz) ); dC (100 MHz, CD3OD): 158.5, 138.6, 132.1, 130.9, 129.3, 128.7, 128.4, 
115.7, 104.1, 77.9, 77.7, 74.9, 71.8, 71.4, 70.8, 62.6, 36.2; HRMS (ESI-TOF): [M-H]-, found 
389.1607. C21H25O7 requires 389.1606.  
 
4.3. 2-(4-hydroxyphenyl)ethyl β-D-glucopyranoside or salidroside (7) 
 
A suspension of 11 (0.23 g, 0.60 mmol) and palladium (100 mg, 0.047 mmol, 5 wt % on activated 
carbon) in dry THF (10 mL) was stirred at 40 oC under a hydrogen gas atmosphere for 24 h.  After 
cooling, the reaction mixture was filtered through a pad of Celite.  The filtrate was then concentrated 
in vacuo.  The crude product was crystallized from water to give 7 in (0.15 g, 83%) as a white solid; 
m.p. 156-158 oC; dH (400 MHz CD3OD) 7.06 (2H, d, J 8.4 Hz), 6.69 (2H, d, J 8.4 Hz), 4.29 (1H, d, J 
7.8 Hz), 4.07 – 3.99 (1H, m), 3.92 – 3.81 (1H, m), 3.74 – 3.61 (2H, m), 3.38 – 3.32 (1H, m), 3.29 – 
3.25 (2H, m), 3.18 (1H, t, J 7.8 Hz), 2.87 – 2.79 (2H, m); dC (100 MHz, CD3OD): 156.8, 130.9, 130.7, 
116.1, 104.3, 78.1, 77.9, 75.1, 72.1, 71.6, 62.7, 36.4; HRMS (ESI-TOF): [M-H]-, found 299.1138. 
C14H19O7 requires 299.1136. (All characterization data matched those previously reported in the 
literature.23)    
 
4.4. 2-(4-benzyloxyphenyl)ethyl 2”,3”,4”,6”-tetra-O-(3,4,5-tribenzyloxybenzoyl)-β-D-
glucopyranoside (12) 
 
A suspension of 11 (0.39 g, 1.0 mmol) and 3,4,5-tribenzyloxybenzoyl chloride (1.84 g, 4.0 mmol) in 
acetonitrile (50 mL) was stirred at room temperature. After 15 minutes, DMAP (0.51 g, 4.2 mmol) was 
added and the mixture continued stirring for an additional 24 h at room temperature. The reaction 
mixture was then concentrated in vacuo. The crude product was dissolved in toluene (20 mL) at 60 oC. 
After cooling, the solution was decanted and purified by flash column chromatography (silica gel, 
MeOH:CH2Cl2 1% to 10%) to give 12 (1.64 g, 79%) as a white solid; m.p. 150-152 oC; Rf (6 % 
EtOAc/Toluene) 0.41; dH (400 MHz CDCl3) 7.43 – 7.15 (73H, m), 6.97 (2H, d, J 8.4 Hz), 6.64 (2H, d, 
J 8.5 Hz), 5.86 (1H, t, J 9.9 Hz), 5.63 (1H, t, J 9.7 Hz), 5.54 (1H, dd, J 10.0, 7.8 Hz), 5.10 – 4.98 (18H, 
m), 4.96 (2H, s), 4.91 (4H, s), 4.84 (2H, s), 4.82 (1H, s), 4.76 (1H, dd, J 12.1, 3.5 Hz), 4.39 (1H, dd, J 
12.1, 5.4 Hz), 4.21 – 4.07 (2H, m), 3.74 – 3.65 (1H, m), 2.89 – 2.71 (2H, m); HRMS (ESI-TOF): 
[M+K]+, found 2117.7392. C133H114O23K requires 2117.7382. 
 
4.5. 2-(4-hydroxyphenyl)ethyl 2”,3”,4”,6”-tetra-O-(3,4,5-trihydroxybenzoyl)-β-D-
glucopyranoside (8) 
 
A suspension of 12 (0.60 g, 0.29 mmol) and palladium (1.10 g, 0.52 mmol, 5 wt % on activated 
carbon) in dry THF (60 mL) was stirred at 40 oC under hydrogen gas atmosphere for 24 h.  After 
cooling, the reaction mixture was filtered through a pad of Celite.  The filtrate was then concentrated 
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in vacuo.  The crude product was dissolved in ethyl acetate (100 mL) and washed with a saturated 
aqueous solution of (NH4)2SO4 (2x20 mL). The organic layer was then dried over Na2SO4, and 
concentrated in vacuo. The crude product was crystallized from water to give 8 (0.19 g, 72%) as a 
white solid; m.p. 190-192 oC; dH (400 MHz (CD3)2CO) 7.20 (2H, s), 7.09 (2H, s), 7.03 (2H, s), 6.96 
(2H, d, J 8.4 Hz), 6.94 (2H, s), 6.61 (2H, d, J 8.2 Hz), 5.86 – 5.76 (1H, m), 5.52 (1H, t, J 9.7 Hz), 5.34 
(1H, dd, J 9.9, 8.2 Hz), 5.08 (1H, d, J 8.0 Hz), 4.52 (1H, dd, J 12.3, 2.1 Hz), 4.38 (1H, dd, J 12.2, 5.1 
Hz), 4.34 – 4.28 (1H, m), 3.98 (1H, dt, J 10.2, 7.1), 3.75 (1H, dt, J 10.0, 7.3 Hz), 2.78 – 2.67 (2H, m). 
dC (100 MHz, (CD3)2CO): 166.4, 165.9, 165.7, 165.5, 156.5, 146.0, 145.9, 145.8, 139.3, 139.1, 139.0, 
130.7, 130.0, 121.5, 121.1, 120.6, 120.5, 115.9, 110.2, 110.1, 110.0, 110.0, 101.6, 73.6, 73.0, 72.5, 
71.7, 69.8, 63.1, 35.9; HRMS (ESI-TOF): [M+Na]+, found 931.1546. C42H36O23Na requires 931.1546. 
(All characterization data matched those previously reported in the literature.21)    
 
4.6. 2-(4-benzyloxyphenyl)ethyl 6”-O-(3,4,5-tribenzyloxybenzoyl)-β-D-glucopyranoside 
(13) 
 
To a solution of 11 (100 mg, 0.26 mmol) and DMAP (15.6 mg, 0.13 mmol) in anhydrous pyridine (5.0 
mL) was added 3,4,5-tribenzyloxybenzoyl chloride24 (344 mg, 0.75 mmol) in small portions over 1 h 
at room temperature. After stirring the reaction for 72 h at room temperature, the reaction mixture was 
concentrated in vacuo. The crude product was dissolved in dichloromethane (50 mL), washed with 
HCl (0.1M, 2x25 mL), aqueous NaHCO3 (25 mL), and brine (2x25 mL). After drying over Na2SO4, 
the organic layer was concentrated in vacuo. The crude product was purified by preparative TLC 
(silica gel, MeOH:CH2Cl2 1:9) to give 13 (54 mg, 24%) as a yellow solid; m.p. 123-125 oC; Rf (10% 
MeOH/CH2Cl2) 0.55; dH (600 MHz (CD3)2CO) δ 7.54 – 7.25 (22H,), 7.08 (2H, d, J 8.3 Hz), 6.82 
(2H, d, J 8.4 Hz), 5.14 (4H, s), 5.12 (2H, s), 4.97 (2H, s), 4.67 (1H, d, J 11.7 Hz), 4.44 (1H, dd, J 11.7, 
6.8 Hz), 4.40 (1H, d, J 7.7 Hz), 3.93 (1H, q, J 8.3 Hz), 3.71 (1H, q, J 8.4 Hz), 3.66 (1H, t, J 6.9 Hz), 
3.47 (2H, dd, J 5.2, 3.3 Hz), 3.28 (1H, t, J 8.0 Hz), 2.85 – 2.76 (2H, m); dC (150 MHz, (CD3)2CO) 
166.2, 158.2, 153.5, 143.2, 138.8, 138.5, 137.9, 131.9, 130.7, 129.3, 129.2, 129.2, 128.9, 128.8, 128.6, 
128.6, 128.5, 128.3, 126.4, 115.4, 109.6, 104.3, 78.0, 75.5, 74.9, 74.8, 71.7, 71.6, 71.5, 70.3, 65.2, 
36.2; HRMS (ESI-TOF): [M+Na]+ found 835.3108. C49H48O11Na requires 835.3089. 
 
4.7. 2-(4-hydroxyphenyl)ethyl 6”-O-(3,4,5-trihydroxybenzoyl)-β-D-glucopyranoside (9) 
 
A suspension of 13 (20 mg, 0.025 mmol) and palladium (50 mg, 0.023 mmol, 5 wt % on activated 
carbon) in dry THF (3 mL) was stirred at 40 oC under a hydrogen gas atmosphere for 24 h.  After 
cooling, the reaction mixture was filtered through a pad of Celite.  The filtrate was then concentrated 
in vacuo.  The crude product was purified by preparative TLC (silica gel, MeOH:CH2Cl2 1:9) to give 
9 (9 mg, 80%) as a yellow oil; Rf (10% MeOH/CH2Cl2) 0.1; dH (400 MHz (CD3)2CO) 7.15 (2H, s), 
7.04 (2H, d, J 7.7 Hz), 6.71 (2H, d, J 7.4 Hz), 4.54 (1H, d, J 11.8 Hz), 4.39 (2H, dd, J 18.1, 6.2 Hz), 
3.92 (1H, q, J 9.0, 6.5 Hz), 3.71 – 3.56 (2H, m), 3.51 – 3.41 (2H, m), 3.23 (1H, t, J 7.8 Hz), 2.77 (2H, 
t, J 7.3 Hz). dC (100 MHz, (CD3)2CO) 166.7, 156.5, 146.0, 138.7, 130.7, 130.2, 121.8, 115.9, 109.9, 
104.3, 77.8, 74.9, 74.8, 71.5, 71.2, 64.4, 36.1; HRMS (ESI-TOF): [M-H]- found 451.1237. C21H23O11 
requires 451.1246. (All characterization data matched those previously reported in the literature.20)    
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